Impact Factor
3.49
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.72
257 total citations
h5-index
25
h5 depth signal
Cited share
89.2%
66 of 74
Total citations
257
Citation footprint
Metric signal
2.78
External metric anchor
Self-citation
0.0%
0 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
88
China
83
Netherlands
75
Japan
72
Spain
48
Citing Fields of Research
Inflammatory Bowel Diseases & Infections
510
Bacteriology
145
Immunology
63
Digestive Disorders
55
Dairy & Animal Science
46
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
969
Articles tracked across the journal lifetime
Indexed publication set
74
66 cited publications
Last 12 months
39
3.3 publications/month
Open access share
56.4%
22 OA publications in the last year
Leading citing country
United States
88 citing publications
Leading citing field
Inflammatory Bowel Diseases & Infections
510 citing publications
Latest tracked publication
17 September 2026
10 recent records available
Coverage & Indexing History
v1n1, 2010-
v1n1, 2010-
Research Focus & Classification
Indexed Subjects
Inflammatory Bowel Diseases & Infections
Broad Categories
Microbiology
Inflammatory Bowel Diseases & Infections
MeSH Descriptors
Biochemical Phenomena
Microbiological Phenomena
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1163/18762891-bja00130
Open DOI
Potential transfer of orally administered probiotics to the upper respiratory tract in children with otitis media with effusion
The upper respiratory tract (URT) microbiome is increasingly recognised as a key determinant of airway health, yet the potential of probiotics to beneficially modulate these communities remains largely unexplored, despite the high burden...
02
DOI 10.1163/18762891-bja00135
Open DOI
Age-associated Akkermansia muciniphila decline links to brown adipose tissue aging: AKK supplementation improves BAT metabolic function
Aging is associated with metabolic decline, brown adipose tissue (BAT) dysfunction, and remodelling of the gut microbiota. Akkermansia muciniphila (AKK) has been implicated in metabolic regulation; however, its relationship with BAT agin...
03
DOI 10.1163/18762891-bja00136
Open DOI
Limosilactobacillus reuteri DSM 17938 versus Lacticaseibacillus rhamnosus GG for paediatric functional abdominal pain: A quasi-experimental analysis
Functional abdominal pain disorders (FAPDs) are common in children and are associated with alterations in the gut–brain axis and intestinal microbiota. Although individual probiotic strains such as Limosilactobacillus reuteri DSM 17938 a...
04
DOI 10.1163/18762891-bja00131
Open DOI
Clinical, microbiological, and immune marker improvement with adjunctive vaginal-spray spore-forming probiotics in women with vaginal infections
Symptomatic vaginal and cervicovaginal conditions include bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), and other sexually transmitted infection (STI)-related conditions with overlapping clinical features. Adjunctive probioti...
05
DOI 10.1163/18762891-bja00126
Open DOI
A high-fibre snack containing Lacticaseibacillus rhamnosus GG for healthy adults: a randomised, double-blind, placebo-controlled crossover trial
Probiotics have gained increasing evidence for their roles in health and disease. Microencapsulation can improve the consistency and efficacy of probiotic-fortified foods by enabling safer delivery to target regions of the gastrointestin...
06
DOI 10.1163/18762891-bja00127
Open DOI
Immunomodulatory effect of molecules secreted by the probiotic strain of Escherichia coli O83:K24:H31
Bacteria and their metabolic products profoundly affect the immune system. Research has shown that early postnatal supplementation with specific probiotic strains, such as Escherichia coli O83:K24:H31 (EcO83), can provide health benefits...
07
DOI 10.1163/18762891-bja00134
Open DOI
Improvement effect of synbiotics intake on stool frequency in constipation-prone healthy participants: placebo-controlled, randomised, double-blind, parallel-group comparison
Synbiotics exert various physiological effects by complementing the physiological functions of both probiotics and prebiotics. Chronic constipation is a prevalent global health concern, and despite several clinical studies utilising synb...
08
DOI 10.1163/18762891-bja00133
Open DOI
The effects of three non-caloric sweeteners on the gut microbiota composition and activity of individuals with overweight or obesity in an in vitro model of the colon
The consumption of sweeteners and sweetness enhancers (S&SE) has increased over the past decades. Recent literature indicates controversies regarding the safety of sweetener consumption, concerning effects on gut microbial composition an...
09
DOI 10.1163/18762891-bja00132
Open DOI
Study on the regulatory effect of Bifidobacterium animalis subsp. lactis BLa80 on immune function of healthy mice and pathogenicity in animals
Bifidobacteria are known for their health-promoting effects, particularly in the context of gut microbiota modulation and immune system support. Bifidobacterium animalis subsp. lactis BLa80 is a novel probiotic strain isolated from human...
10
DOI 10.1163/18762891-bja00128
Open DOI
The immunomodulatory effects of Bifidobacterium lactis XLTG11 on cyclophosphamide-induced immune dysfunction in mice
Previous studies have demonstrated that Bifidobacterium lactis ( B. lactis ) XLTG11 exerts significant immunomodulatory effects. However, the underlying mechanisms remain unclear. To investigate these mechanisms, BALB/c mice were randoml...
Bibliographical & Catalog Notes
Description based on: Vol. 1, no. 1 (2010); title from cover.
Latest issue consulted: Vol. 1, no. 1 (2010).
Print issues ceased with 2023.
Also issued online.